ILLUMICARE IP B.V. (51%);ILLUMICARE IP B.V. (51;PUBLIEKRECHTELIJKE RECHTSPERSOON ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LEIDS UNIVERSITAIR MEDISCH CENTRUM;)
发明人:
MARING MARKWIN. H,LÖWIK CLEMENS WALTHERUS GERARDUS MARIA,BEEK ERMOND R.,BANGWEN XIE
申请号：
NL2011274
公开号：
NL2011274C2
申请日:
2013.08.06
申请国别(地区):
NL
年份:
2015
代理人:
摘要：
A system comprising a targeting molecule for binding necrotic cells； to the system for use as a medicament； to use of the system for diagnosis； to the system for use in treatment of diseases involving necrotic cell death, to a dosage comprising the system； to a method for determining localization of the composition within a sample using said system； and, to a method for treatment of cancers and/or diseases involving necrotic cell death using said system. In particular the invention relates to compositions targeting necrotic cells.
